Dietmar Reusch Editor

Harleen Kaur, PhD, is affiliated with Aurobindo Pharma Ltd., in the Biologics Division, based in Hyderabad, India. Dr Kaur is the lead editor of Monoclonal Antibodies: Physicochemical Analysis. Her research focuses on the analytical development and characterization of large molecules, particularly mAbs, and on bringing therapeutic products from early discovery to commercial launch. Previously she has worked for AstraZeneca both in the United States and India and has extensive experience in technology transfer and development of biologics in a highly regulated environment. She earned her undergraduate degree from Guru Gobind Singh Indraprastha University, Delhi, India, and PhD degree from the National University of Singapore, Singapore. She is the author of many peer-reviewed publications and book chapters in the area of antibody characterization and aptamers. Dietmar Reusch, PhD, is affiliated with Roche Diagnostics GmbH in Germany. His research focuses on the analytical development and characterization of large molecules, particularly mAbs, and on bringing therapeutic products from entry into human to commercial launch.